二甲双胍预防代谢正常猪的缺血性心室颤动
研究在代谢正常的家猪中评估二甲双胍对心肌能量代谢和缺血性心室颤动(VF)的影响。二甲双胍组(30 mg kg-1 day-1口服2-3周,n=36)VF死亡率为12%,未治疗对照组(n=37)为50%(p=0.03)。二甲双胍的保护作用与缺血期间心肌ATP浓度维持和AMPK激活增强相关。
要点
- 二甲双胍组VF死亡率12% vs 未治疗对照组50%(p=0.03)。
- 二甲双胍减轻缺血心肌动作电位缩短(p=0.02)及缺血与非缺血区动作电位时程差异(p<0.001)。
- 二甲双胍对心肌收缩功能、氧耗、葡萄糖或乳酸利用无影响。
核心结论
- 慢性给予临床相关剂量的二甲双胍可降低代谢正常猪缺血性VF的死亡率,该保护作用与缺血期间心肌能量代谢的维持相关。
研究设计与样本
- 家猪随机接受二甲双胍(30 mg kg-1 day-1口服2-3周,n=36)或不治疗(n=37),麻醉后行最多90分钟低流量区域性心肌缺血再灌注45分钟。
主要发现
- 二甲双胍组VF死亡率12% vs 未治疗对照组50%(p=0.03)。
- 二甲双胍组缺血心肌动作电位缩短程度较未治疗对照组减轻(p=0.02),缺血与非缺血区动作电位时程差异较未治疗对照组减小(p<0.001)。
- 二甲双胍对心肌收缩功能、氧耗、葡萄糖或乳酸利用无影响。
- 缺血期间二甲双胍组AMPK激活较未治疗对照组增强、心肌ATP浓度较未治疗对照组维持(各p<0.05)。
临床怎么用
- 作者认为,二甲双胍可能对患有冠心病的非糖尿病人群具有保护作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Metformin is the drug most often used to treat type 2 diabetes. Evidence suggests that metformin may reduce mortality of individuals with type 2 diabetes, but the mechanism of such an effect is unknown and outcomes of metformin treatment in people without diabetes have not been determined. If metformin favourably affected mortality of non-diabetic individuals, it might have even broader therapeutic utility. We evaluated the effect of metformin on myocardial energetics and ischaemic ventricular fibrillation (VF) in metabolically normal pigs. METHODS: Domestic farm pigs were treated with metformin (30 mg kg-1 day-1 orally for 2-3 weeks; n = 36) or received no treatment (n = 37). Under anaesthesia, pigs underwent up to 90 min low-flow regional myocardial ischaemia followed by 45 min of reperfusion. Pigs were monitored for arrhythmia, monophasic action potential morphology, haemodynamics and myocardial substrate utilisation, AMP-activated protein kinase (AMPK) phosphorylation activity and ATP concentration. RESULTS: Death due to VF occurred in 12% of pigs treated with metformin compared with 50% of untreated controls (p = 0.03). The anti-fibrillatory effect of metformin was associated with attenuation of action potential shortening in ischaemic myocardium (p = 0.02) and attenuation of the difference in action potential duration between ischaemic and non-ischaemic regions (p < 0.001) compared with untreated controls. Metformin had no effect on myocardial contractile function, oxygen consumption, or glucose or lactate utilisation. During ischaemia, however, metformin treatment amplified the activation of AMPK and preserved ATP concentration in myocardium compared with untreated controls (each p < 0.05). CONCLUSIONS/INTERPRETATION: Chronic treatment of metabolically normal pigs with metformin at a clinically relevant dose reduces mortality from ischaemic VF. This protection is associated with preservation of myocardial energetics during ischaemia. Maintenance of myocardial ATP concentration during ischaemia is likely to prevent action potential shortening, heterogeneity of repolarisation, and propensity for lethal arrhythmia. The findings suggest that metformin might be protective in non-diabetic individuals with coronary heart disease.
引用
- Lu L, Ye S, Scalzo RL, et al. Metformin prevents ischaemic ventricular fibrillation in metabolically normal pigs. Diabetologia. 2017. PMID: 28497164. doi:10.1007/s00125-017-4287-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。